Medtide Inc. (HKG:3880)

Medtide Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	442.23	336.77	350.84	282.14
Revenue Growth (YoY)	31.31%	-4.01%	24.35%	-
Cost of Revenue	193.24	157.28	150.05	121.44
Gross Profit	248.98	179.5	200.79	160.69
Selling, General & Admin	115.9	71.84	65.72	57.88
Research & Development	27.96	22.47	20.74	17.34
Operating Expenses	144.77	94.91	87.59	77.08
Operating Income	104.21	84.59	113.2	83.61
Interest Expense	-1.14	-0.22	-1.28	-4.44
Interest & Investment Income	13.56	6.92	0.91	0.34
Currency Exchange Gain (Loss)	7.31	5.07	11.94	-2.54
Other Non Operating Income (Expenses)	-48.35	-41.8	-65.53	-20.34
EBT Excluding Unusual Items	75.59	54.55	59.25	56.63
Gain (Loss) on Sale of Investments	3.09	7.59	7.92	0.45
Gain (Loss) on Sale of Assets	-0.23	-0.16	0.38	32.31
Pretax Income	78.45	61.98	67.56	89.39
Income Tax Expense	19.28	13.07	13.58	9.11
Net Income	59.17	48.91	53.98	80.28
Net Income to Common	59.17	48.91	53.98	80.28
Net Income Growth	21.00%	-9.40%	-32.76%	-
Shares Outstanding (Basic)	125	125	100	74
Shares Outstanding (Diluted)	128	125	100	92
Shares Change (YoY)	2.74%	24.41%	8.83%	-
EPS (Basic)	0.47	0.39	0.54	1.09
EPS (Diluted)	0.38	0.39	0.54	1.06
EPS Growth	-3.38%	-27.41%	-49.19%	-
Free Cash Flow	99.49	33.15	42.65	96.49
Free Cash Flow Per Share	0.78	0.27	0.42	1.04
Gross Margin	56.30%	53.30%	57.23%	56.96%
Operating Margin	23.57%	25.12%	32.27%	29.64%
Profit Margin	13.38%	14.52%	15.39%	28.45%
Free Cash Flow Margin	22.50%	9.84%	12.16%	34.20%
EBITDA	130.86	110.66	135.56	106.21
EBITDA Margin	29.59%	32.86%	38.64%	37.64%
D&A For EBITDA	26.65	26.07	22.35	22.59
EBIT	104.21	84.59	113.2	83.61
EBIT Margin	23.57%	25.12%	32.27%	29.64%
Effective Tax Rate	24.57%	21.09%	20.10%	10.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.